心臟生物標記的全球市場(2022年~2028年)
市場調查報告書
商品編碼
1078124

心臟生物標記的全球市場(2022年~2028年)

Global Cardiac Biomarker Market 2022-2028

出版日期: | 出版商: Orion Market Research | 英文 125 Pages | 商品交期: 2-3個工作天內

價格

全球心臟生物標記的市場規模在預測期間內預計將以年複合成長率7.8%成長。由於心血管疾病患病率上升、老年人口增加和技術進步等因素,該市場正在全球擴張。

本報告提供全球心臟生物標記市場相關調查分析,提供市場概要,競爭情形,市場區隔分析,地區分析等資訊。

目錄

第1章 報告摘要

第2章 市場概要與考察

  • 調查範圍
  • 分析師的考察和目前市場趨勢

第3章 競爭情形

  • 主要企業分析
    • 概要
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 主要策略分析

第4章 市場決策要素

  • 促進因素
  • 阻礙因素
  • 市場機會

第5章 市場區隔

  • 全球心臟生物標記市場:各類型
    • 肌酸激梅(CK-MB)
    • 肌鈣蛋白(T·I)
    • 肌紅蛋白
    • 缺血修飾白蛋白
    • 其他
  • 全球心臟生物標記市場:各用途
    • 心肌梗塞
    • 充血性心臟衰竭
    • 急性冠狀動脈症候群
    • 動脈粥狀硬化性心血管疾病
    • 其他
  • 全球心臟生物標記市場:各檢驗地方
    • 臨床檢驗
    • 就地檢驗

第6章 地區分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 其他的歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他的亞太地區
  • 其他地區

第7章 企業簡介

  • Abbott Laboratories Inc.
  • Atlas Medical
  • Becton, Dickson & Co.
  • BG Medicine Inc.
  • BioMerieux S.A.
  • Bio-Rad Laboratories Inc.
  • Cisbio Bioassays SAS
  • Creative Diagnostics
  • Critical Diagnostics
  • F. Hoffmann La Roche Ltd.
  • HyTest Ltd
  • LifeSign LLC
  • Luminex Corp.
  • Meso Scale Diagnostics LLC
  • Myriad RBM
  • Randox Laboratories Ltd.
  • Response Biomedical Corp.
  • Siemens AG
  • Signosis Inc.
  • Thermo Fisher Scientific Inc.
Product Code: OMR2017204

Cardiac Biomarker Market by Type (Creatine Kinase, Troponins, Myoglobin, Ischemia Modified Albumin, and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), by Location of Testing (Laboratory Testing and Point of Care Testing) - Global Industry Share, Growth, Competitive Analysis and Forecast Period 2022-2028

The globalcardiac biomarker market is anticipated to grow at a CAGR of 7.8%during the forecast period. Cardiac biomarkers are substances that are discharged into the blood when the heart is harmed or focused. Estimations of these biomarkers are utilized to analyze acute coronary syndrome (ACS) and cardiac ischemia, and conditions related to lack of bloodstream to the heart. Tests for cardiac biomarkers help measure an individual's risk condition or screen and oversee an individual suspected ofACS and cardiac ischemia.

Several drivers are driving the cardiac biomarker market globally such as a rise in cardiovascular diseases, a rise in the geriatric population, and technological development. The rise in the geriatric population and the rise in cardiac vascular diseases are the major factors that affect the growth of the market as the biomarkers are utilized for detection of the cardiac problems. According to the CDC,one person dies every 36 seconds in the US from cardiovascular disease. About 659,000 people in the US die from heart disease each year-that's 1 in every 4 deaths. Heart disease costs the US about $363 billion each year from 2016 to 2017.

Cardiac biomarkers providean instant and accurate prediction of heart failure after chest pain, and these factors fuel the growth of the market. The market is also affected by the technological development of cardiac biomarkers. Consumption of tobacco or change in lifestyleis other factors that lead to an increase in cardiovascular diseases. According to the American heart association, that heart disease remains the prior cause of mortality in the US.

The cardiac biomarker has been segmented based on type,application, and location of testing. By type, the market issegmented into Creatine Kinase(CK-MB), troponins (T,I), myoglobin, natriuretic peptides( BNP& NT-proBNP), ischemia-modified albumin, and others. Based on application, the market issegmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis, and others. Based onthe location of testing, the market is segmented intopoint of care(POC) testing and laboratory testing.

Geographically, the worldwide cardiac biomarkershowcase is divided into North America, Europe, Asia-Pacific, and the Rest of the World.The Asia-Pacificmarket is considered to be the fastest-growing market globally.The rise in the number of cardiovascular patients in the Asia-Pacific region is considered to rise eventually enabling the cardiac biomarker market to grow. North America and Europe are considered to be the dominating markets due to various factors such as high healthcare expenditure, development in the technology, support from the government, and rise in the key players.

Some of the key players in the cardiac biomarker market include Abbott Laboratories Inc., Becton, Dickson & Co., Bio-Rad Laboratories, Randox Laboratories Ltd., Siemens AG, and Thermo Fisher Scientific Inc., among others.

Research Methodology

The market study of the global cardiac biomarker market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include

  • Financial reports of companies involved in the market.
  • Whitepapers, researchpapers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of the market size andintended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global Cardiac Biomarker Market Research and Analysis by Type
  • Global Cardiac Biomarker Market Research and Analysis by Application
  • Global Cardiac Biomarker Market Research and Analysis by Location of Testing

OMR Report Covers:

  • Comprehensive research methodology of global cardiac biomarker market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global cardiac biomarker market.
  • Insights about market determinants that are stimulating the global cardiac biomarker market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

Category- Biotechnology

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on the Global Cardiac Biomarker Market
  • Recovery Scenario of Global Cardiac Biomarker Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown

.2.1. By Segments

    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Key Strategy Analysis

4. Market Determinants

  • 4.1. Motivators
  • 4.2. Restraints
  • 4.3. Opportunities

5. Market Segmentation

  • 5.1. Global Cardiac Biomarker Market by Type
    • 5.1.1. Creatine Kinase(CK-MB)
    • 5.1.2. Troponins(T,I)
    • 5.1.3. Myoglobin
    • 5.1.4. Ischemia Modified Albumin
    • 5.1.5. Others
  • 5.2. Global Cardiac Biomarker Market by Application
    • 5.2.1. Myocardial Infarction
    • 5.2.2. Congestive Heart Failure
    • 5.2.3. Acute Coronary Syndrome
    • 5.2.4. Atherosclerosis
    • 5.2.5. Others
  • 5.3. Global Cardiac Biomarker Market by Location of Testing
    • 5.3.1. Laboratory Testing
    • 5.3.2. Point of Care Testing

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Abbott Laboratories Inc.
  • 7.2. Atlas Medical
  • 7.3. Becton, Dickson & Co.
  • 7.4. BG Medicine Inc.
  • 7.5. BioMerieux S.A.
  • 7.6. Bio-Rad Laboratories Inc.
  • 7.7. Cisbio Bioassays SAS
  • 7.8. Creative Diagnostics
  • 7.9. Critical Diagnostics
  • 7.10. F. Hoffmann La Roche Ltd.
  • 7.11. HyTest Ltd
  • 7.12. LifeSign LLC
  • 7.13. Luminex Corp.
  • 7.14. Meso Scale Diagnostics LLC
  • 7.15. Myriad RBM
  • 7.16. Randox Laboratories Ltd.
  • 7.17. Response Biomedical Corp.
  • 7.18. Siemens AG
  • 7.19. Signosis Inc.
  • 7.20. Thermo Fisher Scientific Inc.

LIST OF TABLES

  • 1. GLOBAL CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS, 2021-2028 ($ MILLION)
  • 2. GLOBAL CARDIAC BIOMARKER MARKET BY TYPE, 2021-2028 ($ MILLION)
  • 3. GLOBAL CREATINE KINASEMARKET BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL TROPONINSMARKET BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL MYOGLOBIN MARKET BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL ISCHEMIA MODIFIED ALBUMIN MARKET BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL OTHER CARDIAC BIOMARKER MARKET BY REGION, 2021-2028 ($ MILLION)
  • 8. GLOBAL CARDIAC BIOMARKER MARKET BY APPLICATION, 2021-2028 ($ MILLION)
  • 9. GLOBAL MYOCARDIAL INFRACTION BIOMARKER MARKET BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL CONGESTIVE HEART FAILURE BIOMARKER MARKET BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL ACUTE CORONARY SYNDROME BIOMARKER MARKET BY REGION, 2021-2028 ($ MILLION)
  • 12. GLOBAL ATHEROSCLEROSIS BIOMARKER MARKET BY REGION, 2021-2028 ($ MILLION)
  • 13. GLOBAL OTHER CARDIAC BIOMARKER MARKET BY REGION, 2021-2028 ($ MILLION)
  • 14. GLOBAL CARDIAC BIOMARKER MARKET BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 15. GLOBAL CARDIAC BIOMARKER IN LABORATORY TESTING MARKET BY REGION, 2021-2028 ($ MILLION)
  • 16. GLOBAL CARDIAC BIOMARKER IN POINT OF CARE TESTING MARKET BY REGION, 2021-2028 ($ MILLION)
  • 17. GLOBAL CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 18. NORTH AMERICAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 19. NORTH AMERICAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 20. NORTH AMERICAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 21. NORTH AMERICAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 22. EUROPEAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 23. EUROPEAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 24. EUROPEAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 25. EUROPEAN CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 26. ASIA-PACIFIC CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 27. ASIA-PACIFIC CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 28. ASIA-PACIFIC CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)
  • 29. ASIA-PACIFIC CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 30. REST OF THE WORLD CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY TYPE, 2021-2028 ($ MILLION)
  • 31. REST OF THE WORLD CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2021-2028 ($ MILLION)
  • 32. REST OF THE WORLD CARDIAC BIOMARKER MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL CARDIAC BIOMARKER MARKET SHARE BY TYPE, 2021 VS 2028 (%)
  • 2. GLOBAL CARDIAC BIOMARKER MARKET SHARE BY APPLICATION, 2021 VS 2028 (%)
  • 3. GLOBAL CARDIAC BIOMARKER MARKET SHARE BY LOCATION OF TESTING, 2021 VS 2028 (%)
  • 4. GLOBAL CARDIAC BIOMARKER MARKET SHARE BY GEOGRAPHY, 2021 VS 2028, (%)
  • 5. GLOBAL CREATINE KINASE (CK-MB) MARKET BY REGION, 2021 VS 2028 (%)
  • 6. GLOBAL TROPONINS (T, I) MARKET BY REGION, 2021 VS 2028 (%)
  • 7. GLOBAL MYOGLOBIN MARKET BY REGION, 2021 VS 2028 (%)
  • 8. GLOBAL ISCHEMIA MODIFIED ALBUMIN MARKET BY REGION, 2021 VS 2028 (%)
  • 9. GLOBAL OTHER CARDIAC BIOMARKER MARKET BY REGION, 2021 VS 2028 (%)
  • 10. GLOBAL MYOCARDIAL INFRACTION BIOMARKER MARKET BY REGION, 2021 VS 2028 (%)
  • 11. GLOBAL CONGESTIVE HEART FAILURE BIOMARKER MARKET BY REGION, 2021 VS 2028 (%)
  • 12. GLOBAL ACUTE CORONARY SYNDROME BIOMARKER MARKET BY REGION, 2021 VS 2028 (%)
  • 13. GLOBAL ATHEROSCLEROSIS BIOMARKER MARKET BY REGION, 2021 VS 2028 (%)
  • 14. GLOBAL OTHER CARDIAC BIOMARKER MARKET BY REGION, 2021 VS 2028 (%)
  • 15. GLOBAL CARDIAC BIOMARKER IN LABORATORY TESTING MARKET BY REGION, 2021 VS 2028 (%)
  • 16. GLOBAL CARDIAC BIOMARKER IN POINT OF CARE TESTING MARKET BY REGION, 2021 VS 2028 (%)
  • 17. US CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 18. CANADA MARKET CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. UK CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. GERMANY CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. SPAIN CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. FRANCE CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. ITALY CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. REST OF EUROPE CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. INDIA CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. CHINA CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. JAPAN CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. REST OF ASIA-PACIFIC CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)
  • 29. REST OF WORLD CARDIAC BIOMARKER MARKET SIZE, 2021-2028 ($ MILLION)